Prescription drug

• An Evaluation of Regulatory Regimes of Medical Cannabis: What Lessons Can Be Learned for the UK? (27 Sep 2024)
  
• Trends in prescription and cost of Sativex, a cannabinoid-based medicine, in treating patients with multiple sclerosis in England (02 Sep 2024)
  
• Patients’ perspectives on prescription cannabinoid therapies: a cross-sectional, exploratory, anonymous, one-time web-based survey among German patients (02 Sep 2024)
  
• Cannabinoid products for pain management: recommendations from the São Paulo State Society of Anesthesiology (02 Sep 2024)
  
• Medicinal Cannabis Prescribing in Australia: An Analysis of Trends Over the First Five Years (31 Jul 2022)